CYCN
Cyclerion Therapeutics, Inc.
$3.48
+0.02 (+0.58%)
At close · Jul 7
Market Cap
$15.07M
Shares
4,330,314
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 8-K | 2026-04-01 | — | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-02-17 | — | |
| 8-K | 2026-01-06 | 2026-01-03 | |
| 8-K | 2025-12-01 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 10-K/A | 2025-11-12 | 2024-12-31 | |
| 8-K | 2025-09-23 | 2025-09-19 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-06-18 | 2025-06-16 | |
| 8-K | 2025-05-07 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-16 | |
| 8-K | 2025-03-25 | 2025-03-21 | |
| 10-K | 2025-03-04 | 2024-12-31 | |
| 8-K | 2024-12-17 | 2024-12-13 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-06-14 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-14 | |
| 8-K | 2024-04-18 | — | |
| 10-K | 2024-03-05 | 2023-12-31 | |
| 8-K | 2023-12-04 | 2023-12-01 | |
| 8-K | 2023-12-01 | 2023-11-30 | |
| 8-K | 2023-11-24 | 2023-11-19 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-10-23 | 2023-10-17 | |
| 10-Q | 2023-07-28 | 2023-06-30 | |
| 8-K | 2023-07-19 | — | |
| 8-K | 2023-07-12 | — | |
| 8-K | 2023-06-27 | — | |
| 8-K | 2023-06-01 | — | |
| 8-K | 2023-05-25 | 2023-05-19 | |
| 8-K | 2023-05-15 | — | |
| 10-Q | 2023-05-12 | 2023-03-31 | |
| 8-K | 2023-05-12 | 2023-05-11 | |
| DEF 14A | 2023-04-03 | 2023-05-15 | |
| 8-K | 2023-04-03 | 2023-03-31 | |
| 10-K | 2023-03-22 | 2022-12-31 | |
| 8-K | 2023-03-22 | — | |
| 8-K | 2022-11-29 | — | |
| 8-K | 2022-11-22 | — | |
| 10-Q | 2022-11-03 | 2022-09-30 | |
| 8-K | 2022-10-06 | — | |
| 8-K | 2022-09-30 | — | |
| 10-Q | 2022-08-09 | 2022-06-30 |
Showing 1–50 of 97 filings